These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Baseline predictors of worsening apathy in Parkinson's disease: A prospective longitudinal study. Wee N; Kandiah N; Acharyya S; Chander RJ; Ng A; Au WL; Tan LC Parkinsonism Relat Disord; 2016 Feb; 23():95-8. PubMed ID: 26705846 [TBL] [Abstract][Full Text] [Related]
29. Lille Apathy Rating Scale and MDS-UPDRS for Screening Apathy in Parkinson's Disease. Weintraut R; Karádi K; Lucza T; Kovács M; Makkos A; Janszky J; Kovács N J Parkinsons Dis; 2016; 6(1):257-65. PubMed ID: 26889636 [TBL] [Abstract][Full Text] [Related]
30. Latent growth-curve analysis reveals that worsening Parkinson's disease quality of life is driven by depression. Jones JD; Marsiske M; Okun MS; Bowers D Neuropsychology; 2015 Jul; 29(4):603-9. PubMed ID: 25365564 [TBL] [Abstract][Full Text] [Related]
31. Apathy and depression: separate factors in Parkinson's disease. Kirsch-Darrow L; Marsiske M; Okun MS; Bauer R; Bowers D J Int Neuropsychol Soc; 2011 Nov; 17(6):1058-66. PubMed ID: 22040900 [TBL] [Abstract][Full Text] [Related]
32. [Apathy in Parkinson's disease. Impairment in quality of life]. Bottini Bonfanti A; Etcheverry JL; Persi GG; Zezza H; Starkstein S; Gatto EM Medicina (B Aires); 2009; 69(2):253-8. PubMed ID: 19435698 [TBL] [Abstract][Full Text] [Related]
33. Mood and motor trajectories in Parkinson's disease: multivariate latent growth curve modeling. Zahodne LB; Marsiske M; Okun MS; Rodriguez RL; Malaty I; Bowers D Neuropsychology; 2012 Jan; 26(1):71-80. PubMed ID: 22142359 [TBL] [Abstract][Full Text] [Related]
34. Postoperative apathy can neutralise benefits in quality of life after subthalamic stimulation for Parkinson's disease. Martinez-Fernandez R; Pelissier P; Quesada JL; Klinger H; Lhommée E; Schmitt E; Fraix V; Chabardes S; Mertens P; Castrioto A; Kistner A; Broussolle E; Pollak P; Thobois S; Krack P J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):311-8. PubMed ID: 25934016 [TBL] [Abstract][Full Text] [Related]
35. International validation of a behavioral scale in Parkinson's disease without dementia. Rieu I; Martinez-Martin P; Pereira B; De Chazeron I; Verhagen Metman L; Jahanshahi M; Ardouin C; Chéreau I; Brefel-Courbon C; Ory-Magne F; Klinger H; Peyrol F; Schupbach M; Dujardin K; Tison F; Houeto JL; Krack P; Durif F Mov Disord; 2015 Apr; 30(5):705-13. PubMed ID: 25809278 [TBL] [Abstract][Full Text] [Related]
36. Apathy is associated with activities of daily living ability in Parkinson's disease. Laatu S; Karrasch M; Martikainen K; Marttila R Dement Geriatr Cogn Disord; 2013; 35(5-6):249-55. PubMed ID: 23485683 [TBL] [Abstract][Full Text] [Related]
37. Predictors of discrepancies in Parkinson's disease patient and caregiver ratings of apathy, disinhibition, and executive dysfunction before and after diagnosis. Schiehser DM; Liu L; Lessig SL; Song DD; Obtera KM; Burke Iii MM; Earl SR; Vincent Filoteo J J Int Neuropsychol Soc; 2013 Mar; 19(3):295-304. PubMed ID: 23351239 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of an Arabic version of the non-motor symptoms scale in Parkinson's disease. Sellami L; Kacem I; Nasri A; Djebara MB; Sidhom Y; Gargouri A; Gouider R Neurol Sci; 2016 Jun; 37(6):963-8. PubMed ID: 26932938 [TBL] [Abstract][Full Text] [Related]
39. Olfaction and apathy in Parkinson's disease. Cramer CK; Friedman JH; Amick MM Parkinsonism Relat Disord; 2010 Feb; 16(2):124-6. PubMed ID: 19783195 [TBL] [Abstract][Full Text] [Related]
40. Beneficial effects of testosterone replacement for the nonmotor symptoms of Parkinson disease. Okun MS; Walter BL; McDonald WM; Tenover JL; Green J; Juncos JL; DeLong MR Arch Neurol; 2002 Nov; 59(11):1750-3. PubMed ID: 12433262 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]